(Q47977891)

7 February 2018

review article

1 reference

title

The RTS,S/AS01 malaria vaccine in children 5 to 17 months of age at first vaccination. (English)

1 reference

7 February 2018

0 references

1 reference

Pascale Vandoolaeghe

1

1 reference

7 February 2018

Lode Schuerman

series ordinal

2

1 reference

7 February 2018

publication date

14 November 2016

1 reference

7 February 2018

Expert Review of Vaccines

published in

1 reference

7 February 2018

volume

15

1 reference

7 February 2018

issue

12

1 reference

7 February 2018

page(s)

1481-1493

1 reference

7 February 2018

Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

copyright license

start time

18 November 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

The changing risk of Plasmodium falciparum malaria infection in Africa: 2000-10: a spatial and temporal analysis of transmission intensity

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

High level of resistance in the mosquito Anopheles gambiae to pyrethroid insecticides and reduced susceptibility to bendiocarb in north-western Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

From the circumsporozoite protein to the RTS, S/AS candidate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

The RTS,S vaccine candidate for malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

Status of vaccine research and development of vaccines for malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

Clinical development of RTS,S/AS malaria vaccine: a systematic review of clinical Phase I-III trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

Design of a phase III multicenter trial to evaluate the efficacy of the RTS,S/AS01 malaria vaccine in children across diverse transmission settings in Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

T cell responses to the RTS,S/AS01e and RTS,S/AS02D malaria candidate vaccines administered according to different schedules to Ghanaian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

Randomized controlled trial of RTS,S/AS02D and RTS,S/AS01E malaria candidate vaccines given according to different schedules in Ghanaian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

Evaluation of the safety and immunogenicity of the RTS,S/AS01 E malaria candidate vaccine when integrated in the expanded program of immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

A statistical interaction between circumsporozoite protein-specific T cell and antibody responses and risk of clinical malaria episodes following vaccination with RTS,S/AS01E

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

Effect of the pre-erythrocytic candidate malaria vaccine RTS,S/AS01E on blood stage immunity in young children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

Safety of the malaria vaccine candidate, RTS,S/AS01E in 5 to 17 month old Kenyan and Tanzanian Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

Safety and efficacy of the RTS, S/AS01 E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

Statistical methodology for the evaluation of vaccine efficacy in a phase III multi-centre trial of the RTS, S/AS01 malaria vaccine in African children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

Efficacy and safety of the RTS,S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

Development of standardized laboratory methods and quality processes for a phase III study of the RTS, S/AS01 candidate malaria vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

Assessment of severe malaria in a multicenter, phase III, RTS, S/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient care

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

Immunogenicity and safety of the candidate RTS,S/AS01 vaccine in young Nigerian children: a randomized, double-blind, lot-to-lot consistency trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

Seven-Year Efficacy of RTS,S/AS01 Malaria Vaccine among Young African Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

Association of transmission intensity and age with clinical manifestations and case fatality of severe Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

Standardized data collection for multi-center clinical studies of severe malaria in African children: establishing the SMAC network

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

Clinical features of severe malaria associated with death: a 13-year observational study in the Gambia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

RTS,S/AS02A malaria vaccine does not induce parasite CSP T cell epitope selection and reduces multiplicity of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

Impact of RTS,S/AS02(A) and RTS,S/AS01(B) on genotypes of P. falciparum in adults participating in a malaria vaccine clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

The time-course of protection of the RTS,S vaccine against malaria infections and clinical disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

Induction of Plasmodium falciparum-specific CD4+ T cells and memory B cells in Gabonese children vaccinated with RTS,S/AS01(E) and RTS,S/AS02(D)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

The effect of immunization schedule with the malaria vaccine candidate RTS,S/AS01E on protective efficacy and anti-circumsporozoite protein antibody avidity in African infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

Antigen-specific IL-2 secretion correlates with NK cell responses after immunization of Tanzanian children with the RTS,S/AS01 malaria vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

Pooled analysis of safety data from pediatric Phase II RTS,S/AS malaria candidate vaccine trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

RTS,S Malaria Vaccine and Increased Mortality in Girls

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

Artemisinin resistance--the clock is ticking

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14760584.2016.1236689

10.1080/14760584.2016.1236689

21 January 2018

Identifiers

DOI

1 reference

7 February 2018

release_nhmcr4hfwrb2tntz3plp5lda6i

Fatcat ID

0 references

PubMed ID

27841689

1 reference

7 February 2018